0001437749-19-024861.txt : 20191226 0001437749-19-024861.hdr.sgml : 20191226 20191226104832 ACCESSION NUMBER: 0001437749-19-024861 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191222 FILED AS OF DATE: 20191226 DATE AS OF CHANGE: 20191226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pellegrino Joseph P JR CENTRAL INDEX KEY: 0001365733 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 191309109 MAIL ADDRESS: STREET 1: 68 BEACON STREET CITY: BOSTON STATE: MA ZIP: 02108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 rdgdoc.xml FORM 4 X0306 4 2019-12-22 0001158895 LEMAITRE VASCULAR INC LMAT 0001365733 Pellegrino Joseph P JR C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 1 1 Chief Financial Officer Common Stock 2019-12-22 4 M 0 6 0 A 30032 D Common Stock 2019-12-22 4 F 0 181 35.48 D 29851 D Common Stock 2019-12-24 4 S 0 300 36.0725 D 29551 D Dividend Equivalent Rights 2019-12-22 4 M 0 6 0 D Common Stock 6 16 D Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 22, 2017. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. This transaction was effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $36.04 to $36.11. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. /s/ Laurie A. Churchill, Attorney-in-fact 2019-12-26